Global Scopolamine Market Research Report 2025(Status and Outlook)
Description
Report Overview
Scopolamine is a tropane alkaloid drug derived from plants of the nightshade family (Solanaceae), primarily used for its anticholinergic effects to prevent nausea and vomiting associated with motion sickness, postoperative recovery, and chemotherapy. It works by blocking acetylcholine receptors in the brain, particularly in the vestibular system and vomiting center, which helps reduce spasms and secretions in the gastrointestinal tract. Available in transdermal patches, tablets, and injectable forms, scopolamine is highly effective but carries potential side effects such as drowsiness, dry mouth, blurred vision, and, in rare cases, hallucinations or confusion due to its central nervous system activity. Its market is driven by demand in healthcare settings, particularly for surgical patients and travelers, though regulatory controls exist due to its abuse potential in criminal contexts (e.g., ""devil's breath""). The growing emphasis on non-invasive drug delivery systems, such as transdermal patches, further supports its adoption. However, competition from alternative antiemetics (e.g., ondansetron) and concerns over side effects may limit growth. Geographically, North America and Europe dominate usage due to established medical protocols, while emerging markets show potential with increasing healthcare access.
The global Scopolamine market size was estimated at USD 11.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.24% during the forecast period.
This report provides a deep insight into the global Scopolamine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Scopolamine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Scopolamine market in any manner.
Global Scopolamine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Market Segmentation (by Type)
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Market Segmentation (by Application)
Tablets
Injection
Patches
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Scopolamine Market
Overview of the regional outlook of the Scopolamine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Scopolamine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Scopolamine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Scopolamine is a tropane alkaloid drug derived from plants of the nightshade family (Solanaceae), primarily used for its anticholinergic effects to prevent nausea and vomiting associated with motion sickness, postoperative recovery, and chemotherapy. It works by blocking acetylcholine receptors in the brain, particularly in the vestibular system and vomiting center, which helps reduce spasms and secretions in the gastrointestinal tract. Available in transdermal patches, tablets, and injectable forms, scopolamine is highly effective but carries potential side effects such as drowsiness, dry mouth, blurred vision, and, in rare cases, hallucinations or confusion due to its central nervous system activity. Its market is driven by demand in healthcare settings, particularly for surgical patients and travelers, though regulatory controls exist due to its abuse potential in criminal contexts (e.g., ""devil's breath""). The growing emphasis on non-invasive drug delivery systems, such as transdermal patches, further supports its adoption. However, competition from alternative antiemetics (e.g., ondansetron) and concerns over side effects may limit growth. Geographically, North America and Europe dominate usage due to established medical protocols, while emerging markets show potential with increasing healthcare access.
The global Scopolamine market size was estimated at USD 11.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.24% during the forecast period.
This report provides a deep insight into the global Scopolamine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Scopolamine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Scopolamine market in any manner.
Global Scopolamine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Market Segmentation (by Type)
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Market Segmentation (by Application)
Tablets
Injection
Patches
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Scopolamine Market
Overview of the regional outlook of the Scopolamine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Scopolamine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Scopolamine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
134 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Scopolamine
- 1.2 Key Market Segments
- 1.2.1 Scopolamine Segment By Type
- 1.2.2 Scopolamine Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Scopolamine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Scopolamine Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Scopolamine Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Scopolamine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Scopolamine Product Life Cycle
- 3.3 Global Scopolamine Sales By Manufacturers (2020-2025)
- 3.4 Global Scopolamine Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Scopolamine Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Scopolamine Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Scopolamine Market Competitive Situation And Trends
- 3.8.1 Scopolamine Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Scopolamine Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Scopolamine Industry Chain Analysis
- 4.1 Scopolamine Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Scopolamine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Scopolamine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Scopolamine Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Scopolamine Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Scopolamine Sales Market Share By Type (2020-2025)
- 6.3 Global Scopolamine Market Size Market Share By Type (2020-2025)
- 6.4 Global Scopolamine Price By Type (2020-2025)
- 7 Scopolamine Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Scopolamine Market Sales By Application (2020-2025)
- 7.3 Global Scopolamine Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Scopolamine Sales Growth Rate By Application (2020-2025)
- 8 Scopolamine Market Sales By Region
- 8.1 Global Scopolamine Sales By Region
- 8.1.1 Global Scopolamine Sales By Region
- 8.1.2 Global Scopolamine Sales Market Share By Region
- 8.2 Global Scopolamine Market Size By Region
- 8.2.1 Global Scopolamine Market Size By Region
- 8.2.2 Global Scopolamine Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Scopolamine Sales By Country
- 8.3.2 North America Scopolamine Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Scopolamine Sales By Country
- 8.4.2 Europe Scopolamine Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Scopolamine Sales By Region
- 8.5.2 Asia Pacific Scopolamine Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Scopolamine Sales By Country
- 8.6.2 South America Scopolamine Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Scopolamine Sales By Region
- 8.7.2 Middle East And Africa Scopolamine Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Scopolamine Market Production By Region
- 9.1 Global Production Of Scopolamine By Region(2020-2025)
- 9.2 Global Scopolamine Revenue Market Share By Region (2020-2025)
- 9.3 Global Scopolamine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Scopolamine Production
- 9.4.1 North America Scopolamine Production Growth Rate (2020-2025)
- 9.4.2 North America Scopolamine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Scopolamine Production
- 9.5.1 Europe Scopolamine Production Growth Rate (2020-2025)
- 9.5.2 Europe Scopolamine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Scopolamine Production (2020-2025)
- 9.6.1 Japan Scopolamine Production Growth Rate (2020-2025)
- 9.6.2 Japan Scopolamine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Scopolamine Production (2020-2025)
- 9.7.1 China Scopolamine Production Growth Rate (2020-2025)
- 9.7.2 China Scopolamine Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Alkaloids Of Australia
- 10.1.1 Alkaloids Of Australia Basic Information
- 10.1.2 Alkaloids Of Australia Scopolamine Product Overview
- 10.1.3 Alkaloids Of Australia Scopolamine Product Market Performance
- 10.1.4 Alkaloids Of Australia Business Overview
- 10.1.5 Alkaloids Of Australia Swot Analysis
- 10.1.6 Alkaloids Of Australia Recent Developments
- 10.2 Boehringer Ingelheim
- 10.2.1 Boehringer Ingelheim Basic Information
- 10.2.2 Boehringer Ingelheim Scopolamine Product Overview
- 10.2.3 Boehringer Ingelheim Scopolamine Product Market Performance
- 10.2.4 Boehringer Ingelheim Business Overview
- 10.2.5 Boehringer Ingelheim Swot Analysis
- 10.2.6 Boehringer Ingelheim Recent Developments
- 10.3 Fine Chemicals Corporation
- 10.3.1 Fine Chemicals Corporation Basic Information
- 10.3.2 Fine Chemicals Corporation Scopolamine Product Overview
- 10.3.3 Fine Chemicals Corporation Scopolamine Product Market Performance
- 10.3.4 Fine Chemicals Corporation Business Overview
- 10.3.5 Fine Chemicals Corporation Swot Analysis
- 10.3.6 Fine Chemicals Corporation Recent Developments
- 10.4 Phytex Australia
- 10.4.1 Phytex Australia Basic Information
- 10.4.2 Phytex Australia Scopolamine Product Overview
- 10.4.3 Phytex Australia Scopolamine Product Market Performance
- 10.4.4 Phytex Australia Business Overview
- 10.4.5 Phytex Australia Recent Developments
- 10.5 Alchem International
- 10.5.1 Alchem International Basic Information
- 10.5.2 Alchem International Scopolamine Product Overview
- 10.5.3 Alchem International Scopolamine Product Market Performance
- 10.5.4 Alchem International Business Overview
- 10.5.5 Alchem International Recent Developments
- 10.6 Guangzhou Hanfang
- 10.6.1 Guangzhou Hanfang Basic Information
- 10.6.2 Guangzhou Hanfang Scopolamine Product Overview
- 10.6.3 Guangzhou Hanfang Scopolamine Product Market Performance
- 10.6.4 Guangzhou Hanfang Business Overview
- 10.6.5 Guangzhou Hanfang Recent Developments
- 10.7 Alkaloids Corporation
- 10.7.1 Alkaloids Corporation Basic Information
- 10.7.2 Alkaloids Corporation Scopolamine Product Overview
- 10.7.3 Alkaloids Corporation Scopolamine Product Market Performance
- 10.7.4 Alkaloids Corporation Business Overview
- 10.7.5 Alkaloids Corporation Recent Developments
- 10.8 Luyin
- 10.8.1 Luyin Basic Information
- 10.8.2 Luyin Scopolamine Product Overview
- 10.8.3 Luyin Scopolamine Product Market Performance
- 10.8.4 Luyin Business Overview
- 10.8.5 Luyin Recent Developments
- 11 Scopolamine Market Forecast By Region
- 11.1 Global Scopolamine Market Size Forecast
- 11.2 Global Scopolamine Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Scopolamine Market Size Forecast By Country
- 11.2.3 Asia Pacific Scopolamine Market Size Forecast By Region
- 11.2.4 South America Scopolamine Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Scopolamine By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Scopolamine Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Scopolamine By Type (2026-2033)
- 12.1.2 Global Scopolamine Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Scopolamine By Type (2026-2033)
- 12.2 Global Scopolamine Market Forecast By Application (2026-2033)
- 12.2.1 Global Scopolamine Sales (K Mt) Forecast By Application
- 12.2.2 Global Scopolamine Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
